Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Antonio Giordano, MD, PhD


Medical Oncology

Make an Appointment

Antonio Giordano, MD, PhD

Physician

  • Physician
  • Assistant Professor of Medicine, Harvard Medical School

Clinical Interests

  • Circulating Biomarkers
  • Drug Development
  • Immune-Oncology

Diseases Treated

Contact Information

  • Office Phone Number617-632-3800
  • Fax617-632-1930

Bio

Dr. Giordano completed his medical school and oncology fellowship at University of Naples Federico II in Italy in 2004 and 2009, respectively. The passion for research was the motivation behind his pursuit of starting a PhD Program in medical oncology and immunology at the Second University of Naples and participating in the exchange program with The University of Texas MD Anderson Cancer Center. During the four years spent as faculty at MD Anderson, he consolidated his solid foundation in breast clinical oncology, transitional and basic science research, and has made tremendous contributions to the field of breast cancer biology and circulating biomarkers. He subsequently worked as faculty at MUSC in Charleston SC from 2016 to 2020. In 2020, Dr. Giordano joined the staff of Brigham and Women's Hospital and Dana-Farber Cancer Institute, where he is a medical oncologist and clinical investigator in the Breast Oncology Center.

Board Certification:

  • Internal Medicine, 2016
  • Medical Oncology, 2019

Fellowship:

  • University of Naples Federico II

Residency:

  • Medical University of South Carolina

Medical School:

  • University of Naples Federico II

Research

Antonio Giordano, MD, PhD is a breast medical oncologist at Dana-Farber Cancer Institute. During his PhD program in medical oncology and immunology, he studied the biology and clinical relevance of circulating tumor cells (CTC) and cancer-initiating stem cells in breast cancer. During the four years spent as faculty at MD Anderson, he consolidated his solid foundation in breast clinical oncology, transitional and basic science research, and has made tremendous contributions to the field of breast cancer biology. He received two prestigious grant awards, the 2012 AACR-Bristol-Myers Squibb Oncology fellowship in clinical cancer research and the 2012 ASCO Young Investigator Award, for a project on single-nucleus DNA sequencing to investigate CTC origin in breast cancer patients. In 2016 he joined the Division of Hematology/Oncology at MUSC in Charleston SC and received the K12 Paul Calabresi & Translational Oncology Training Program Award with a laboratory project on triple-negative breast cancer and Polo-like kinase 1. Dr. Giordano was awarded the METAVIVOR Early Career Investigator Award to support a phase 1 clinical trial with a Plk1 inhibitor in metastatic breast cancer patients with TP53 mutation. At Dana-Farber Cancer Institute he will be a Clinical Investigator in the Breast Oncology Center and Center for Cancer Therapeutic Innovation. Dr. Giordano believes that oncology is a diversified discipline and to be involved in research to beat cancer would be his prerogative as a translational oncologist.

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions

Dana-Farber Cancer Institute - Chestnut Hill
300 Boylston Street
Newton, MA 02459
Get Directions

Ratings

Top